Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hilmi

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical Nutrition ESPEN|September 28, 2025
Implementation and challenges of prehabilitation in gastrointestinal oncology: A national cross-sectional survey in FranceEva Ester Molina Beltran, Nora Dollet Nedellec, Marc Hilmi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2024
Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic studyMarc Hilmi, Ines Khati, Anthony Turpin, et al.
Bulletin Du Cancer|November 23, 2021
[Goals, motivations, and difficulties of young oncology residents]Marc Hilmi, Elisabeth Ashton, Matthieu Delaye, et al.
Therapeutic Advances in Medical Oncology|July 23, 2020
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsPascal Hammel, Carole Vitellius, Émeric Boisteau, et al.
Pharmaceuticals (Basel, Switzerland)|October 24, 2020
Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance StudyMarc Hilmi, Stéphane Ederhy, Xavier Waintraub, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinomaMarc Hilmi, Jérôme Cros, Francesco Puleo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2022
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric studyMarc Hilmi, Natacha Naoun, Alice Boilève, et al.
The Journal of Pathology|February 12, 2025
Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approachMarc Hilmi, Flore Delecourt, Jérôme Raffenne, et al.
BMJ Supportive & Palliative Care|July 16, 2020
Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary surveyMarc Hilmi, Anna Pellat, Olivier Benoit, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical Nutrition ESPEN|September 28, 2025
Implementation and challenges of prehabilitation in gastrointestinal oncology: A national cross-sectional survey in FranceEva Ester Molina Beltran, Nora Dollet Nedellec, Marc Hilmi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2024
Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic studyMarc Hilmi, Ines Khati, Anthony Turpin, et al.
Bulletin Du Cancer|November 23, 2021
[Goals, motivations, and difficulties of young oncology residents]Marc Hilmi, Elisabeth Ashton, Matthieu Delaye, et al.
Therapeutic Advances in Medical Oncology|July 23, 2020
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsPascal Hammel, Carole Vitellius, Émeric Boisteau, et al.
Pharmaceuticals (Basel, Switzerland)|October 24, 2020
Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance StudyMarc Hilmi, Stéphane Ederhy, Xavier Waintraub, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinomaMarc Hilmi, Jérôme Cros, Francesco Puleo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2022
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric studyMarc Hilmi, Natacha Naoun, Alice Boilève, et al.
The Journal of Pathology|February 12, 2025
Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approachMarc Hilmi, Flore Delecourt, Jérôme Raffenne, et al.
BMJ Supportive & Palliative Care|July 16, 2020
Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary surveyMarc Hilmi, Anna Pellat, Olivier Benoit, et al.
Pageof 5